Burden of substance use disorders, mental illness, and correlates of infectious diseases among soon-to-be released prisoners in Azerbaijan

Drug and Alcohol Dependence

Volumn 151, Issue , 2015, Pages 68-75

  Azbel, Lyuba ^a   Wickersham, Jeffrey A ^a   Wegman, Martin P ^a   Polonsky, Maxim ^a   Suleymanov, Murad ^b   Ismayilov, Rafik ^c   Dvoryak, Sergey ^d   Rotberga, Signe ^e   Altice, Frederick L ^a,f  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b State Phytosanitary Control Service   (Azerbaijan)

^c Independent Assistance and Consultancy Center For the Sake of Civil Society   (Azerbaijan)

^d UKRAINIAN INSTITUTE ON PUBLIC HEALTH POLICY   (Ukraine)

^e Head of UNODC Program Office in Kazakhstan   (Kazakhstan)

^f YALE UNIVERSITY   (United States)

Author keywords

Azerbaijan; Hepatitis C virus; HIV AIDS; Opioid substitution therapy; Prisons; Substance abuse

Indexed keywords

AMPHETAMINE; ANTIRETROVIRUS AGENT; DIAMORPHINE; OPIATE; NARCOTIC AGENT;

ADULT; ALCOHOL USE DISORDER; ANAL INTERCOURSE; ANXIETY DISORDER; ARTICLE; AZERBAIJAN; CD4 LYMPHOCYTE COUNT; COITUS; CORRELATIONAL STUDY; DEPRESSION; DRUG SELF ADMINISTRATION; FEMALE; HEALTH SURVEY; HEART DISEASE; HEPATITIS B; HEPATITIS C; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; HYPERTENSION; INFECTION; MALE; MEN WHO HAVE SEX WITH MEN; MENTAL DISEASE; PRIORITY JOURNAL; PRISONER; SEROPREVALENCE; SEX DIFFERENCE; SOCIAL SUPPORT; SUBSTANCE ABUSE; SYPHILIS; TRANSACTIONAL SEX; UNPROTECTED SEX; WORKPLACE; COMMUNICABLE DISEASES; HIV INFECTIONS; PREVALENCE; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; USSR;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ADULT; AZERBAIJAN; COMMUNICABLE DISEASES; FEMALE; HEALTH SURVEYS; HEPATITIS B; HEROIN; HIV INFECTIONS; HUMANS; MALE; NARCOTICS; PREVALENCE; PRISONERS; SUBSTANCE-RELATED DISORDERS; SYPHILIS; USSR;

EID: 84929945299     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.02.034     Document Type: Article

References (45)

1. Altice F.L., Kamarulzaman A., Soriano V.V., Schechter M., Friedland G.H. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet 2010, 376:367-387.
2. Altice F.L., Marinovich A., Khoshnood K., Blankenship K.M., Springer S.A., Selwyn P.A. Correlates of HIV infection among incarcerated women: implications for improving detection of HIV infection. J. Urban Health 2005, 82:312-326.
3. Altice F.L., Mostashari F., Selwyn P.A., Checko P.J., Singh R., Tanguay S., Blanchette E.A. Predictors of HIV infection among newly sentenced male prisoners. J. Acquir. Immune Defic. Syndr. 1998, 18:444-453.
4. Azbel L., Wickersham J.A., Grishaev Y., Dvoryak S., Altice F.L. Burden of infectious diseases, substance use disorders, and mental illness among Ukrainian prisoners transitioning to the community. PLOS ONE 2013, 8:e59643.
5. Azbel L., Wickersham J.A., Grishaev Y., Dvoryak S., Altice F.L. Correlates of HIV infection and being unaware of HIV status among soon-to-be-released Ukrainian prisoners. J. Int. AIDS Soc. 2014, 17:19005.
6. Berenguer J., Alvarez-Pellicer J., Martin P.M., Lopez-Aldeguer J., Von-Wichmann M.A., Quereda C., Mallolas J., Sanz J., Tural C., Bellon J.M., Gonzalez-Garcia J. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009, 50:407-413. GESIDA3603/5607 Study Group.
7. Borisenko K.K., Tichonova L.I., Renton A.M. Syphilis and other sexually transmitted infections in the Russian Federation. Int. J. STD AIDS 1999, 10:665-668.
8. Botros B.A., Aliyev Q.M., Saad M.D., Michael A.A., Sanchez J.L., Carr J.K., Earhart K.C. HIV infection and associated risk factors among long-distance truck drivers travelling through Azerbaijan. Int. J. STD AIDS 2009, 20:477-482.
9. Cook C., Kanaef N. Global State of Harm Reduction 2008: Mapping the Response to Drug-related HIV and Hepatitis C Epidemics 2008, International Harm Reduction Program, London.
10. Degenhardt L., Whiteford H.A., Ferrari A.J., Baxter A.J., Charlson F.J., Hall W.D., Freedman G., Burstein R., Johns N., Engell R.E., Flaxman A., Murray C.J., Vos T. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013, 382:1564-1574.
11. Dutta A., Wirtz A., Stanciole A., Oelrichs R., Semini I., Baral S., Pretorius C., Haworth C., Hader S., Beyrer C., Cleghorn F. The Global HIV Epidemics among People Who Inject Drugs 2013, World Bank, Washington, DC. 10.1596/1978-1590-8213-9776-1593.
12. Eaton W.W., Muntaner C., Smith C., Tien A., Ybarra M. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, Mawah, NJ 2004.
13. Flanigan T., Zaller N., Beckwith C.G., Bazerman L.B., Rana A., Gardner A., Wohl D.A., Altice F.L. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J. Acquir. Immune Defic. Syndr. 2010, 55:S78-S83.
14. Gadirova H.A.E., Alakbarov F. Antiretroviral Therapy in Penitentiary System of Azerbaijan 2011, Poster at IAS Conference on HIV Pathogenesis.
15. Ghanem K.G., Hutton H.E., Zenilman J.M., Zimba R., Erbelding E.J. Audio computer assisted self interview and face to face interview modes in assessing response bias among STD clinic patients. Sex. Transm. Infect. 2005, 81:421-425.
16. Gowing L., Farrell M., Bornemann R., Sullivan L., Ali R. Substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst. Rev. 2008, CD004145.
17. Haig T. Randomized controlled trial proves effectiveness of methadone maintenance treatment in prison. Can. HIV AIDS Policy Law Rev. 2003, 8:48.
18. Hill A., Khoo S., Fortunak J., Simmons B., Ford N. Minimum costs for producing hepatitis C direct-acting antivirals for use in large-scale treatment access programs in developing countries. Clin. Infect. Dis. 2014, 58:928-936.
19. Hunt N., Tyrell S. Stratified Sampling 2001, (accessed 04.10.12). http://www.coventry.ac.uk/ec/~nhunt/meths/strati.html.
20. Joint United Nations Programme on HIV/AIDS (UNAIDS) The Gap Report. Geneva, Switzerland 2014, Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2014/unaids_gap_report_en.pdf (accessed 24.08.14).
21. Kazatchkine M. Drug use, HIV, HCV and TB: major interlinked challenges in Eastern Europe and Central Asia. J. Int. AIDS Soc. 2014, 17:19501.
22. Kerr T., Wodak A., Elliott R., Montaner J.S., Wood E. Opioid substitution and HIV/AIDS treatment and prevention. Lancet 2004, 364:1918-1919.
23. Kinlock T.W., Gordon M.S., Schwartz R.P., Fitzgerald T.T., O'Grady K.E. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease. J. Subst. Abuse Treat. 2009, 37:277-285.
24. Kvitsinadze L., Tvildiani D., Pkhakadze G. HIV/AIDS prevalence in the Southern Caucasus. Georgian Med. News 2010, 26-36.
25. McLellan A.T., Cacciola J.C., Alterman A.I., Rikoon S.H., Carise D. The Addiction Severity Index at 25: origins, contributions and transitions. Am. J. Addict. 2006, 15:113-124.
26. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., Argeriou M. The fifth edition of the addiction severity index. J. Subst. Abuse Treat. 1992, 9:199-213.
27. Ministry of Health of the Republic of Azerbaijan National Report on Monitoring Progress towards the UNGASS Declaration of Commitment on HIV/AIDS. Reporting Period: January 2012-December 2013, Baku 2014.
28. Paul A. Azerbaijan and the Two EUs. Today's Zaman, Istanbul, Turkey 2014, Available at: http://www.todayszaman.com/columnist/amanda-paul/azerbaijan-and-the-two-eus_352182.html (accessed 05.09.14).
29. Saunders J.B., Aasland O.G., Babor T.F., de la Fuente J.R., Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II. Addiction 1993, 88:791-804.
30. Springer S.A., Altice F.L. Managing HIV/AIDS in correctional settings. Curr. HIV/AIDS Rep. 2005, 2:165-170.
31. The World Bank Azerbaijan Partnership Program Snapshot, Geneva 2014.
32. Thompson M.A., Mugavero M.J., Amico K.R., Cargill V.A., Chang L.W., Gross R., Orrell C., Altice F.L., Bangsberg D.R., Bartlett J.G., Beckwith C.G., Dowshen N., Gordon C.M., Horn T., Kumar P., Scott J.D., Stirratt M.J., Remien R.H., Simoni J.M., Nachega J.B. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann. Intern. Med. 2012, 156:817-833.
33. UNAIDS Otchetnost' o dostupnosti progresse v osushchestvlenii global'nykh mer v otvet na SPID: 2010-2011 2012.
34. United Nations Office on Drugs and Crime Accessibility of HIV Prevention, Treatment and Care Services for People who Use Drugs and Incarcerated People in Azerbaijan, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan and Uzbekistan: Legislative and Policy Analysis and Recommendations for Reform 2010, United Nations Office on Drugs and Crime, Regional Office for Central Asia.
35. Uuskula A., Puur A., Toompere K., DeHovitz J. Trends in the epidemiology of bacterial sexually transmitted infections in eastern Europe, 1995-2005. Sex. Transm. Infect. 2010, 86:6-14.
36. Vagenas P., Azbel L., Polonsky M., Kerimi N., Mamyrov M., Dvoryak S., Altice F.L. A review of medical and substance use co-morbidities in Central Asian prisons: implications for HIV prevention and treatment. Drug Alcohol Depend. 2013, 132(Suppl. 1):S25-S31.
37. Vickerman P., Platt L., Jolley E., Rhodes T., Kazatchkine M.D., Latypov A. Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelling. Int. J. Drug Policy 2014, 25:1163-1173.
38. Walmsley R. World Prison Population List (10th Edition) 2014, University of Essex, London, England, Available at: http://www.prisonstudies.org/sites/prisonstudies.org/files/resources/downloads/wppl_2010.pdf (accessed 14.07.14).
39. Ware J.E., Keller S.D., Gandek B., Brazier J.E., Sullivan M. Evaluating translations of health status questionnaires, methods from the IQOLA project. International Quality of Life Assessment. Int. J. Technol. Assess. Health Care 1995, 11:525-551.
40. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992, 30:473-483.
41. WHO/UNAIDS/UNICEF Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector, Geneva 2010.
42. Wickersham J.A., Marcus R., Kamarulzaman A., Zahari M.M., Altice F.L. Implementing methadone maintenance treatment in prisons in Malaysia. Bull. World Health Organ. 2013, 91:124-129.
43. Wickersham J.A., Zahari M.M., Azar M.M., Kamarulzaman A., Altice F.L. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug Alcohol Depend. 2013, 132:378-382.
44. Zabransky T., Mravcik V., Talu A., Jasaitis E. Post-Soviet Central Asia: a summary of the drug situation. Int. J. Drug Policy 2014, 25:1186-1194.
45. Zung W.W. A rating instrument for anxiety disorders. Psychosomatics 1971, 12:371-379.